|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Bleeding patterns after immediate initiation of an oral compared with a |
| vaginal hormonal contraceptive. |
| Westhoff C; Osborne LM; Schafer JE; Morroni C |
| Obstetrics and Gynecology. 2005 Jul;106(1):89-96. |
| This study compared 84-day bleeding patterns after immediate initiation of a triphasic oral contraceptive with a 25-µg |
| daily dose of ethinyl estradiol (E2) compared with the contraceptive vaginal ring, which has a 15-µg daily dose of |
| ethinyl E2. This was an open-label controlled trial. We randomly assigned 201 women to immediate start of a |
| contraceptive pill or immediate start of the ring in a 1:1 allocation ratio. Our primary outcome was difference in mean |
| bleeding - spotting days per woman according to treatment assignment. Secondary outcomes were differences in |
| World Health Organization- defined menstrual indices, differences in perceived bleeding changes, and differences in |
| bleeding according to cycle day at the start of method. The mean bleeding-spotting days in the 84-day reference |
| period for all subjects was 19.2 days (17.0 days for ring users and 21.4 days for pill users, mean difference 4.4 days). |
| Using the World Health Organization menstrual indices, the ring users experienced fewer days or episodes of |
| bleeding-spotting and shorter intervals. Among ring users, no baseline characteristics were associated with bleeding |
| outcomes. Older nulliparous pill users, however, reported more bleeding-spotting days. Significantly more ring users |
| reported a decrease in duration of bleeding compared with pill users (P < .01). We found no significant differences in |
| bleeding patterns based on analysis of cycle day at study enrollment. Our study shows advantageous bleeding |
| patterns for subjects using the contraceptive vaginal ring. It also confirms our previous findings that immediate start |
| of hormonal contraception is an acceptable alternative to waiting for menses. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Bleeding patterns after immediate initiation of an oral |
| compared with a vaginal hormonal contraceptive.", is(are) Westhoff C; Osborne LM; Schafer JE; Morroni C. The |
| source of this article is "Obstetrics and Gynecology. 2005 Jul;106(1):89-96.". This article was published in 2005 in |
| English language(s). (PubHealth.info® Document ID: CONT1T 74-06. All rights reserved with PubHealth.info) PIN: 74 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |